Headache is describes as a painful sensation in any part of the head, the pain can be dull or sharp and it may also occur with other symptoms. Headache and facial pain are common complaints in OPD facilities. Headaches are treated with medication, stress management and biofeedback.
Trigeminal neuralgia is the most common term associated with a chronic facial pain condition that affects the trigeminal nerve, which carries sensation from face to brain. Trigeminal neuralgia pain most commonly affects only one side.
Primary headaches are those that aren’t due to any underlying medical condition. It includes
Cluster headaches.
Migraine.
New daily persistent headaches (NDPH).
Tension headaches.
Secondary headaches are mostly symptoms of other diseases, such as:
Disease of blood vessels in the brain.
Head injury.
High blood pressure (hypertension).
Infection.
Medication overuse.
Sinus congestion.
Trauma.
Tumor.
Market Analysis: In the foreseeable term, the migraine market is expected to rise at a considerable CAGR. .Migraine is a medical disease in which people suffer from intense headaches. From 2018 to 2025, the global migraine medications market is predicted to increase at a CAGR of 3.1 percent, from $1,713 million in 2017 to $2,190 million in 2025. Migraine medicines are used to treat headaches that are caused by migraines.
Anti Migraine Drugs Market size is expected to reach $10.56 billion by 2025, with a CAGR of 9.7% over the forecast period of 2020-2025.
Around 15% of people worldwide suffer from migraine, and the market will be driven by growing use of anti-migraine drugs during the projected period.
ALSO READ Neurology Neurosurgery Neuroscience Neuropsychiatry Pain Disorder and Management Central Nervous System Pediatric Neurology Neuro-Oncology and Brain Tumors Neurophysiology Neuroimmunology Neuropathology Neuroimaging Neurodegenerative disease and Neurodegeneration Neurological Disorders Sleep Disorder Stroke Movement Disorders Parkinsons Disease Epilepsy Multiple Sclerosis Alzheimers Disease and Dementia Neuromuscular Disease Case Studies and Clinical Trials Novel Treatment Strategies Speech Disorders Demyelinating Disorders Cerebrovascular Disorders Autoimmune and Inflammatory Disorders Neuropathy Headache and Facial Pain Diagnosis and Screening of Neurological Disorders Neuropharmacology and Neurochemistry Stem Cells and Neuroregeneration Cognitive Neuroscience Motor System Disorders Behavioral Neurology Computational Neuroscience Neurogenetics Spinal Neurosurgery Pediatric Neurosurgery Stereotactic and Functional Neurosurgery Neurovascular Surgery Intraoperative Neurophysiology Peripheral Nerve Surgery Robotics in Neurosurgery Latest advancement in Brain Surgery Skull Base Surgery Trauma and Critical Care Child Psychology Social Cognitive Neuroscience Neurophysics Neuroradiology Neurorobotics Advanced Imaging Techniques Personalized Medicine Neuroinformatics Gene Therapy Neural Interface and Brain-Computer Interface BCI Neurorehabilitation Regenerative Medicine and Stem Cell Therapy Telemedicine in Neurology Nano-Neuroscience Neurosurgical Innovations Neuroethics Precision Psychiatry Neuromodulation and New Therapeutic Approaches Microbiome and Neurological Health Neurological Implications of COVID-19
Tags
Neurology Conferences 2024 Japan
Muscular Dystrophy Conferences
Neurodegenerative Disorders Conferences
Neurology Conferences Europe
Dementia Conferences
Neurology Conferences 2025 USA
Psychiatry Conferences
Stroke Conferences
Clinical Neurology Conferences
Neurology Conferences
Alzheimer's Disease Conferences
Sleep Disorders Conferences
Child Psychology Conferences
Neuroscience Conferences 2024 Dubai
Spinal Disorders Conferences